Exiqon Raises $3.7M to Bolster Capital Resources, Expand Array, qPCR Inventory

CEO Lars Kongsbak said that the proceeds will be used to strengthen the company's capital resources and to expand its inventory in light of growing demand for its qPCR arrays, miRcury microRNA microarrays, and other products and services.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.